CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
80.70
+0.28 (0.35%)
At close: Jan 6, 2026, 4:00 PM EST
80.80
+0.10 (0.12%)
After-hours: Jan 6, 2026, 7:57 PM EST
CVS Health Market Cap
CVS Health has a market cap or net worth of $102.44 billion as of January 6, 2026. Its market cap has increased by 84.85% in one year.
Market Cap
102.44B
Enterprise Value
172.96B
1-Year Change
84.85%
Ranking
Category
Stock Price
$80.70
Market Cap Chart
Since December 1, 1998, CVS Health's market cap has increased from $19.55B to $102.44B, an increase of 424.05%. That is a compound annual growth rate of 6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 102.09B | 1.34% |
| Dec 31, 2025 | 100.74B | 78.34% |
| Dec 31, 2024 | 56.49B | -44.41% |
| Dec 29, 2023 | 101.61B | -17.02% |
| Dec 30, 2022 | 122.45B | -10.08% |
| Dec 31, 2021 | 136.18B | 52.33% |
| Dec 31, 2020 | 89.40B | -7.50% |
| Dec 31, 2019 | 96.65B | 44.79% |
| Dec 31, 2018 | 66.75B | -9.11% |
| Dec 29, 2017 | 73.44B | -12.73% |
| Dec 30, 2016 | 84.15B | -22.27% |
| Dec 31, 2015 | 108.26B | -1.94% |
| Dec 31, 2014 | 110.41B | 29.61% |
| Dec 31, 2013 | 85.19B | 41.32% |
| Dec 31, 2012 | 60.28B | 13.56% |
| Dec 30, 2011 | 53.08B | 12.35% |
| Dec 31, 2010 | 47.25B | 3.99% |
| Dec 31, 2009 | 45.43B | 10.07% |
| Dec 31, 2008 | 41.28B | -29.69% |
| Dec 31, 2007 | 58.71B | 130.61% |
| Dec 29, 2006 | 25.46B | 18.34% |
| Dec 30, 2005 | 21.51B | 19.30% |
| Dec 31, 2004 | 18.03B | 26.40% |
| Dec 31, 2003 | 14.27B | 45.39% |
| Dec 31, 2002 | 9.81B | -15.18% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |